Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
New strategies for prevention and treatment of type 2 diabetes (T2D) require improved insight into disease etiology. We analyzed 386,731 common single-nucleotide polymorphisms (SNPs) in 1464 patients with T2D and 1467 matched controls, each characterized for measures of glucose metabolism, lipids, obesity, and blood pressure. With collaborators (FUSION and WTCCC/UKT2D), we identified and confirmed three loci associated with T2D—in a noncoding region near CDKN2A and CDKN2B , in an intron of IGF2BP2 , and an intron of CDKAL1 —and replicated associations near HHEX and in SLC30A8 found by a recent whole-genome association study. We identified and confirmed association of a SNP in an intron of glucokinase regulatory protein (GCKR) with serum triglycerides. The discovery of associated variants in unsuspected genes and outside coding regions illustrates the ability of genome-wide association studies to provide potentially important clues to the pathogenesis of common diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This idea, combined with the development of efficient methods for surveying large numbers of SNPs, has led to the many recent genome-wide association (GWA) studies that have detected SNPs that are significantly associated with breast cancer79,80, colorectal cancer81,82, type 2 diabetes83–86 and heart disease87,88, among other diseases.”
From Linkage disequilibrium--understanding the evolutionary past and mapping the medical future. (2008) · cites this paper as [83]
In the citing paper
“These studies identified single-nucleotide polymorphisms (SNPs) in the second intron of the IGF2BP2 gene, particularly rs4402960 and rs1470579, as being significantly associated with an increased risk of T2D across various populations.”
From IMPlications of IMP2 in RNA Biology and Disease (2025) · cites this paper as [70]
In the citing paper
“The association between IMP2 and T2D was first identified through genome-wide association studies (GWAS) in 2007, with three independent research groups demonstrating a strong link between genetic variants in the IGF2BP2 gene and T2D risk [69,70,71].”
From IMPlications of IMP2 in RNA Biology and Disease (2025) · cites this paper as [70]
In the citing paper
“The complexity of the genetic factors that contribute to type 2 diabetes risk is substantial (272,273).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [272]
In the citing paper
“Recent genome-wide association studies have identified .30genetic factors that increase the risk for type 2 diabetes (272,273).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [272]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Principal components analysis corrects for stratification in genome-wide association studies
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & Reich, D. (2006) · Nature Genetics · doi:10.1038/ng1847 · Cited by 10,248
A haplotype map of the human genome
The International HapMap Consortium (2005) · Nature · doi:10.1038/nature04226 · Cited by 5,858
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
Hugot, J.-P., Chamaillard, M., Zouali, H., Lesage, S., Cézard, J.-P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., et al. (2001) · Nature · doi:10.1038/35079107 · Cited by 5,591
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
Self-citationA genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007) · Science · doi:10.1126/science.1142382 · Cited by 2,753
Self-citationVariant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194
Efficiency and power in genetic association studies
de Bakker, P. I. W., Yelensky, R., Pe'er, I., Gabriel, S. B., Daly, M. J., & Altshuler, D. (2005) · Nature Genetics · doi:10.1038/ng1669 · Cited by 1,688
Self-citationDeeb, S. S., Fajas, L., Nemoto, M., Pihlajamäki, J., Mykkänen, L., Kuusisto, J., Laakso, M., Fujimoto, W., & Auwerx, J. (1998) · Nature Genetics · doi:10.1038/3099 · Cited by 1,319
Research works printed but not linked: 3
- R. A. Fisher, Trans. R. Soc. Edinb.52, 399 (1918).
- The Wellcome Trust Case Control Consortium Nature in press.
- F. C. Nielsen, J. Nielsen, J. Christiansen, Scand. J. Clin. Lab. Invest. Suppl.234, 93 (2001).
Cited by
Items 401–500 of 1,017
Type 2 Diabetes Risk Alleles Are Associated With Reduced Size at Birth
Freathy, R. M., Bennett, A. J., Ring, S. M., Shields, B., Groves, C. J., Timpson, N. J., Weedon, M. N., Zeggini, E., Lindgren, C. M., Lango, H., et al. (2009) · Diabetes · doi:10.2337/db08-1739 · Cited by 142
“Consistent with previous studies confirming associations of the five SNPs with type 2 diabetes (16-20), we used an additive”
MethodSchulze, M. B., Weikert, C., Pischon, T., Bergmann, M. M., Al-Hasani, H., Schleicher, E., Fritsche, A., Häring, H.-U., Boeing, H., & Joost, H.-G. (2009) · Diabetes Care · doi:10.2337/dc09-0197 · Cited by 142
Wallace, D. C. (2008) · Genetics · doi:10.1534/genetics.104.91769 · Cited by 140
Sabater-Lleal, M., Huang, J., Chasman, D., Naitza, S., Dehghan, A., Johnson, A. D., Teumer, A., Reiner, A. P., Folkersen, L., Basu, S., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.002251 · Cited by 141
Genetic dissection of type 2 diabetes
Ridderstråle, M., & Groop, L. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.002 · Cited by 156
Self-citationO’Neill, C. M., Lu, C. Y., Corbin, K. L., Sharma, P. R., Dula, S. B., Carter, J. D., Ramadan, J. W., Xin, W., Lee, J. K., & Nunemaker, C. S. (2013) · Endocrinology · doi:10.1210/en.2012-2138 · Cited by 154
The genomic architecture of segmental duplications and associated copy number variants in dogs
Nicholas, T. J., Cheng, Z., Ventura, M., Mealey, K., Eichler, E. E., & Akey, J. M. (2009) · Genome Research · doi:10.1101/gr.084715.108 · Cited by 140
Nettleton, J. A., McKeown, N. M., Kanoni, S., Lemaitre, R. N., Hivert, M.-F., Ngwa, J., van Rooij, F. J. A., Sonestedt, E., Wojczynski, M. K., Ye, Z., et al. (2010) · Diabetes Care · doi:10.2337/dc10-1150 · Cited by 139
“The locus was originally identified in the Diabetes Genetics Initiative GWAS for triglyceride levels (27).”
Links between Thyroid Hormone Action, Oxidative Metabolism, and Diabetes Risk?
Crunkhorn, S., & Patti, M.-E. (2008) · Thyroid · doi:10.1089/thy.2007.0249 · Cited by 140
O'Donnell, C. J., Cupples, L. A., D'Agostino, R. B., Fox, C. S., Hoffmann, U., Hwang, S.-J., Ingellson, E., Liu, C., Murabito, J. M., Polak, J. F., et al. (2007) · BMC Medical Genetics · doi:10.1186/1471-2350-8-s1-s4 · Cited by 139
“Interestingly, there was an association of this chromosome 9 region with CAC in one replication study [24], and this same chromosome 9 region was associated with diabetes mellitus in three other recent GWAS [20-22].”
Newman, A. B., Walter, S., Lunetta, K. L., Garcia, M. E., Slagboom, P. E., Christensen, K., Arnold, A. M., Aspelund, T., Aulchenko, Y. S., Benjamin, E. J., et al. (2010) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glq028 · Cited by 138
A Genome-Wide Association Study of the Metabolic Syndrome in Indian Asian Men
Zabaneh, D., & Balding, D. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011961 · Cited by 137
Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity
Usher, C. L., Handsaker, R. E., Esko, T., Tuke, M. A., Weedon, M. N., Hastie, A. R., Cao, H., Moon, J. E., Kashin, S., Fuchsberger, C., et al. (2015) · Nature Genetics · doi:10.1038/ng.3340 · Cited by 151
Self-citationSimonis-Bik, A. M., Nijpels, G., van Haeften, T. W., Houwing-Duistermaat, J. J., Boomsma, D. I., Reiling, E., van Hove, E. C., Diamant, M., Kramer, M. H. H., Heine, R. J., et al. (2010) · Diabetes · doi:10.2337/db09-1048 · Cited by 137
Pancreatic β-cell tRNA hypomethylation and fragmentation link TRMT10A deficiency with diabetes
Cosentino, C., Toivonen, S., Diaz Villamil, E., Atta, M., Ravanat, J.-L., Demine, S., Schiavo, A. A., Pachera, N., Deglasse, J.-P., Jonas, J.-C., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky839 · Cited by 137
The diabetes gene Hhex maintains δ-cell differentiation and islet function
Zhang, J., McKenna, L. B., Bogue, C. W., & Kaestner, K. H. (2014) · Genes & Development · doi:10.1101/gad.235499.113 · Cited by 137
Challenges and future directions for studying effects of host genetics on the gut microbiome
Sanna, S., Kurilshikov, A., van der Graaf, A., Fu, J., & Zhernakova, A. (2022) · Nature Genetics · doi:10.1038/s41588-021-00983-z · Cited by 151
Detecting rare variants for complex traits using family and unrelated data
Zhu, X., Feng, T., Li, Y., Lu, Q., & Elston, R. C. (2010) · Genetic Epidemiology · doi:10.1002/gepi.20449 · Cited by 135
Nutrigenomics research for personalized nutrition and medicine
Kaput, J. (2008) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2008.02.005 · Cited by 147
Worldwide population differentiation at disease-associated SNPs
Myles, S., Davison, D., Barrett, J., Stoneking, M., & Timpson, N. (2008) · BMC Medical Genomics · doi:10.1186/1755-8794-1-22 · Cited by 133
“643 rs10946398 T2D [27, 31] 12 54756892 0.221 0.063 0.049 0.367 0.884 0.343 0.438 0.318 0.219 0.056 0.481 rs11805303 CD [33] 1 67387537 IL23 0.085 0.483 0.492 0.421 0.27 0.456 0.303 0.513 0.547 0.121 0.446 rs12708716 T1D [32] 16 11087374 KIAA0 350 0.071 0.57 0.398 0.648 0.411 0.592 0.611 0.645 0.773 0.849 0.571”
InfluentialBoesgaard, T. W., Zilinskaite, J., Vänttinen, M., Laakso, M., Jansson, P., Hammarstedt, A., Smith, U., Stefan, N., Fritsche, A., Häring, H., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-0955-6 · Cited by 146
Pathomechanisms of Type 2 Diabetes Genes
Staiger, H., Machicao, F., Fritsche, A., & Häring, H.-U. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0017 · Cited by 133
Huang, J., Ellinghaus, D., Franke, A., Howie, B., & Li, Y. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.3 · Cited by 147
van den Oord, E. J. C. G., Kuo, P.-H., Hartmann, A. M., Webb, B. T., Möller, H.-J., Hettema, J. M., Giegling, I., Bukszár, J., & Rujescu, D. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.9.1062 · Cited by 131
The TaqMan Method for SNP Genotyping
Shen, G.-Q., Abdullah, K. G., & Wang, Q. K. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-411-1_19 · Cited by 138
Shen, G.-Q., Rao, S., Martinelli, N., Li, L., Olivieri, O., Corrocher, R., Abdullah, K. G., Hazen, S. L., Smith, J. D., Barnard, J., et al. (2007) · Journal of Human Genetics · doi:10.1007/s10038-007-0230-6 · Cited by 133
Bioenergetics, the origins of complexity, and the ascent of man
Wallace, D. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914635107 · Cited by 141
Genetic and microbiome influence on lipid metabolism and dyslipidemia
Matey-Hernandez, M. L., Williams, F. M. K., Potter, T., Valdes, A. M., Spector, T. D., & Menni, C. (2018) · Physiological Genomics · doi:10.1152/physiolgenomics.00053.2017 · Cited by 130
Chasman, D. I., Paré, G., Zee, R. Y. L., Parker, A. N., Cook, N. R., Buring, J. E., Kwiatkowski, D. J., Rose, L. M., Smith, J. D., Williams, P. T., et al. (2008) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.108.773168 · Cited by 131
Learning From Molecular Genetics
McCarthy, M. I., & Hattersley, A. T. (2008) · Diabetes · doi:10.2337/db08-0343 · Cited by 147
“It would be wrong to extrapolate too far: the known variants account for only a small proportion of overall genetic risk, and the focus on lean type 2 diabetes cases, which has characterized several of the genome-wide association (GWA) studies (58,59), may have generated a bias toward detection of variants detrimental…”
BackgroundBurkhardt, R., Kenny, E. E., Lowe, J. K., Birkeland, A., Josowitz, R., Noel, M., Salit, J., Maller, J. B., Pe'er, I., Daly, M. J., et al. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.172288 · Cited by 130
Self-citationRecent advances in the molecular genetics of type 2 diabetes mellitus
Brunetti, A., Chiefari, E., & Foti, D. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i2.128 · Cited by 129
Ganesh, S. K., Arnett, D. K., Assimes, T. L., Basson, C. T., Chakravarti, A., Ellinor, P. T., Engler, M. B., Goldmuntz, E., Herrington, D. M., Hershberger, R. E., et al. (2013) · Circulation · doi:10.1161/01.cir.0000437913.98912.1d · Cited by 127
Bonàs‐Guarch, S., Guindo-Martínez, M., Miguel-Escalada, I., Grarup, N., Sebastián, D., Rodríguez-Fos, E., Sánchez, F., Planas-Fèlix, M., Cortés-Sánchez, P., González, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02380-9 · Cited by 146
Self-citationIdentification of Type 2 Diabetes Genes in Mexican Americans Through Genome-Wide Association Studies
Hayes, M. G., Pluzhnikov, A., Miyake, K., Sun, Y., Ng, M. C. Y., Roe, C. A., Below, J. E., Nicolae, R. I., Konkashbaev, A., Bell, G. I., et al. (2007) · Diabetes · doi:10.2337/db07-0482 · Cited by 129
Igoillo‐Esteve, M., Genin, A., Lambert, N., Désir, J., Pirson, I., Abdulkarim, B., Simonis, N., Drielsma, A., Marselli, L., Marchetti, P., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003888 · Cited by 136
Exercise therapy in Type 2 diabetes
Praet, S. F. E., & van Loon, L. J. C. (2009) · Acta Diabetologica · doi:10.1007/s00592-009-0129-0 · Cited by 128
“polymorphisms (SNPs) related to beta-cell function predispose to the development of Type 2 diabetes [8–11], clinical characteristics such as obesity and lack of physical”
BackgroundDiabetes Genetics Replication and Meta-analysis (DIAGRAM) Consortium, Parra, E. J., Below, J. E., Krithika, S., Valladares, A., Barta, J. L., Cox, N. J., Hanis, C. L., Wacher, N., Garcia-Mena, J., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2172-y · Cited by 128
Penetrance of Polygenic Obesity Susceptibility Loci across the Body Mass Index Distribution
Abadi, A., Alyass, A., Robiou-du-Pont, S., Bolker, B. M., Singh, P., Mohan, V., Díaz, R., Engert, J. C., Yusuf, S., Gerstein, H. C., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.10.007 · Cited by 131
Timpson, N. J., Lindgren, C. M., Weedon, M. N., Randall, J., Ouwehand, W. H., Strachan, D. P., Rayner, N. W., Walker, M., Hitman, G. A., Doney, A. S. F., et al. (2009) · Diabetes · doi:10.2337/db08-0906 · Cited by 127
“Furthermore, this SNP was not associated with type 2 diabetes in the Diabetes Genetics Initiative (DGI) and Finland–United States Investigation of NIDDM Genetics (FUSION) GWA scans, both of which featured predominantly nonobese case subjects (4,5).”
BackgroundResultWen, J., Rönn, T., Olsson, A., Yang, Z., Lu, B., Du, Y., Groop, L., Ling, C., & Hu, R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009153 · Cited by 127
Self-citationPolygenic determinants of severe hypertriglyceridemia
Wang, J., Ban, M. R., Zou, G. Y., Cao, H., Lin, T., Kennedy, B. A., Anand, S., Yusuf, S., Huff, M. W., Pollex, R. L., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn188 · Cited by 127
“For SNP genotyping, we selected markers that were replicably associated with plasma TG in at least two studies (3,7,11) and that showed relatively strong association in each study (3,7,11).”
MethodDoria, A. (2008) · JAMA · doi:10.1001/jama.2008.649 · Cited by 127
Liew, C. W., Bochenski, J., Kawamori, D., Hu, J., Leech, C. A., Wanic, K., Malecki, M., Warram, J. H., Qi, L., Krolewski, A. S., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci36849 · Cited by 126
Prediction of postpartum diabetes in women with gestational diabetes mellitus
Ekelund, M., Shaat, N., Almgren, P.-E., Groop, L., & Berntorp, K. E. (2009) · Diabetologia · doi:10.1007/s00125-009-1621-3 · Cited by 137
“These genes include the CDKAL1, CDKN2A/2B, HHEX, IGF2BP2, SLC30A8, TCF7L2, KCNJ11, GCK, HNF1A, PPARG and FTO [11–13].”
BackgroundSelf-citationRafiq, S., Frayling, T. M., Murray, A., Hurst, A. J., Stevens, K. N., Weedon, M. N., Henley, W., Ferrucci, L., Bandinelli, S., Corsi, A.-M., et al. (2007) · Genes and Immunity · doi:10.1038/sj.gene.6364414 · Cited by 135
Pathophysiology of Type 2 Diabetes in Children and Adolescents
Valaiyapathi, B., Gower, B. A., & Ashraf, A. P. (2019) · Current Diabetes Reviews · doi:10.2174/1573399814666180608074510 · Cited by 196
Cudejko, C., Wouters, K., Fuentes, L., Hannou, S. A., Paquet, C., Bantubungi, K., Bouchaert, E., Vanhoutte, J., Fleury, S., Remy, P., et al. (2011) · Blood · doi:10.1182/blood-2010-10-313106 · Cited by 125
Molecular Time: An Often Overlooked Dimension to Cardiovascular Disease
Martino, T. A., & Sole, M. J. (2009) · Circulation Research · doi:10.1161/circresaha.109.206201 · Cited by 125
At-Risk Variant in TCF7L2 for Type II Diabetes Increases Risk of Schizophrenia
Hansen, T. F., Ingason, A., Djurovic, S., Melle, I. S., Fenger, M., Gústafsson, Ó., Jakobsen, K. D., Rasmussen, H. B., Tosato, S., Rietschel, M., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.01.031 · Cited by 145
The Power of Meta-Analysis in Genome-Wide Association Studies
Panagiotou, O. A., Willer, C. J., Hirschhorn, J. N., & Ioannidis, J. P. A. (2013) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091212-153520 · Cited by 124
Self-citationVolkov, P., Olsson, A. H., Gillberg, L., Jørgensen, S. W., Brøns, C., Eriksson, K.-F., Groop, L., Jansson, P.-A., Nilsson, E., Rönn, T., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0157776 · Cited by 123
Self-citationInsights into pancreatic islet cell dysfunction from type 2 diabetes mellitus genetics
Krentz, N. A. J., & Gloyn, A. L. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0325-0 · Cited by 142
Han, X., Luo, Y., Ren, Q., Zhang, X., Wang, F., Sun, X., Zhou, X., & Ji, L. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-81 · Cited by 124
“In the early GWAS, common variants in IGF2BP2, CDKAL1, SLC30A8, HHEX, CDKN2A/B, FTO, and TCF2 loci were reported to increase the risk of T2D in Caucasians [1-6], and KCNQ1 was recently discovered as a new diabetogenic gene in Japanese samples [7].”
BackgroundInfluentialWallace, D. C. (2013) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2012.0267 · Cited by 141
“One important type 2 diabetes locus is the peroxisomeproliferating-activated receptor g (PPARg) gene that has been associated with diabetes in GWAS studies [13,20,21].”
BackgroundAssociation of risk variants for type 2 diabetes and hyperglycemia with gestational diabetes
Huopio, H., Cederberg, H., Vangipurapu, J., Hakkarainen, H., Pääkkönen, M., Kuulasmaa, T., Heinonen, S., & Laakso, M. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0286 · Cited by 121
The Importance of Being Modified
Agris, P. F., Narendran, A., Sarachan, K. L., Väre, V. Y. P., & Eruysal, E. (2017) · The Enzymes · doi:10.1016/bs.enz.2017.03.005 · Cited by 153
Andersson, S. A., Olsson, A. H., Esguerra, J. L. S., Heimann, E., Ladenvall, C., Edlund, A., Salehi, A., Taneera, J., Degerman, E., Groop, L., et al. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.08.009 · Cited by 122
“Cells were seeded on poly-L-leucine (Sigma-Aldrich) coated dishes and cultured overnight in RPMI-1640 medium (SVA, Sweden) supplemented with 10 mM glucose, 5% (vol/vol) fetal calf serum, 100 μg/ml streptomycin, 100 IU/ml penicillin and 2 mM L-Glutamine (Sigma-Aldrich).”
InfluentialSelf-citationMoragues, M., Comadran, J., Waugh, R., Milne, I., Flavell, A. J., & Russell, J. (2010) · Theoretical and Applied Genetics · doi:10.1007/s00122-010-1273-1 · Cited by 121
Association of Ketone Body Levels With Hyperglycemia and Type 2 Diabetes in 9,398 Finnish Men
Mahendran, Y., Vangipurapu, J., Cederberg, H., Stančáková, A., Pihlajamäki, J., Soininen, P., Kangas, A. J., Paananen, J., Civelek, M., Saleem, N. K., et al. (2013) · Diabetes · doi:10.2337/db12-1363 · Cited by 122
“The C allele of rs780094 of GCKR has been previously reported to be associated with fasting glycemia, type 2 diabetes, insulin resistance, and decreased levels of total and VLDL triglycerides, decreased levels of alanine and isoleucine, and elevated levels of glutamine (36-40).”
BackgroundGaulton, K. J., Willer, C. J., Li, Y., Scott, L. J., Conneely, K. N., Jackson, A. U., Duren, W. L., Chines, P. S., Narisu, N., Bonnycastle, L. L., et al. (2008) · Diabetes · doi:10.2337/db07-1731 · Cited by 122
“3%) of the overall risk of type 2 diabetes (12).”
BackgroundBoes, E., Coassin, S., Kollerits, B., Heid, I. M., & Kronenberg, F. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.11.003 · Cited by 135
“The variation of the recognition site for SstI within the 3´-untranslated region of APOC3 has consistently shown an association with both plasma triglyceride and HDLC levels, whereas common variants of some other promising candidate genes, such as LIPC, were not as consistent (Busch et al., 2000).”
BackgroundInfluentialGenetics Insights in the Relationship Between Type 2 Diabetes and Coronary Heart Disease
Goodarzi, M. O., & Rotter, J. I. (2020) · Circulation Research · doi:10.1161/circresaha.119.316065 · Cited by 141
Insulin-degrading enzyme prevents α-synuclein fibril formation in a nonproteolytical manner
Sharma, S. K., Chorell, E., Steneberg, P., Vernersson-Lindahl, E., Edlund, H., & Wittung-Stafshede, P. (2015) · Scientific Reports · doi:10.1038/srep12531 · Cited by 119
Gilbert, E. R., & Liu, D. (2012) · Epigenetics · doi:10.4161/epi.21238 · Cited by 119
Squalene synthase: a critical enzyme in the cholesterol biosynthesis pathway
Do, R., Kiss, R., Gaudet, D., & Engert, J. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2008.01099.x · Cited by 120
“Publicly available genome-wide datasets do not reveal any association of 21 FDFT1 variants and apoB, LDL-C or TC (Table 2) (81, 82).”
BackgroundProper analysis of secondary phenotype data in case‐control association studies
Lin, D. Y., & Zeng, D. (2009) · Genetic Epidemiology · doi:10.1002/gepi.20377 · Cited by 118
“…quantitative traits, such as height [Weedon et al., 2007; Sanna et al., 2008; Weedon et al., 2008; Lettre et al., 2008; Gudbjartsson et al., 2008], body mass index (BMI) [Frayling et al., 2007; Loos et al., 2008], and lipid levels [Saxena et al., 2007; Willer et al., 2008; Kathiresan et al., 2008].”
Genome-wide association studies and type 2 diabetes
Wheeler, E., & Barroso, I. (2011) · Briefings in Functional Genomics · doi:10.1093/bfgp/elr008 · Cited by 119
GWAS of 165,084 Japanese individuals identified nine loci associated with dietary habits
Matoba, N., Akiyama, M., Ishigaki, K., Kanai, M., Takahashi, A., Momozawa, Y., Ikegawa, S., Ikeda, M., Iwata, N., Hirata, M., et al. (2020) · Nature Human Behaviour · doi:10.1038/s41562-019-0805-1 · Cited by 125
Cruz, M., Valladares‐Salgado, A., García-Mena, J., Ross, K., Edwards, M., Ángeles-Martínez, J., Ortega‐Camarillo, C., Escobedo, J., Burguete-García, A. I., Wacher, N. H., et al. (2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1082 · Cited by 125
Lin, X., Song, K. S., Lim, N., Yuan, X., Johnson, T., Abderrahmani, A., Vollenweider, P., Stirnadel-Farrant, H. A., Sundseth, S. S., Lai, E., et al. (2009) · Diabetologia · doi:10.1007/s00125-008-1254-y · Cited by 130
“Recently a series of susceptibility genes for this disease have been discovered [6–10].”
BackgroundGlucokinase regulatory protein: complexity at the crossroads of triglyceride and glucose metabolism
Raimondo, A., Rees, M. G., & Gloyn, A. L. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000155 · Cited by 118
“The first human genetic evidence of a role for GCKR in lipid metabolism was the association of a more than 400 kb genomic region, encompassing GCKR, with plasma triglyceride levels in Europeans via GWAS [7].”
BackgroundInfluentialBellomo, E. A., Meur, G., & Rutter, G. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.246082 · Cited by 117
Ruano, D., Abecasis, G. R., Glaser, B., Lips, E. S., Cornelisse, L. N., de Jong, A. P. H., Evans, D. M., Smith, G. D., Timpson, N. J., Smit, A. B., et al. (2010) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.12.006 · Cited by 118
Genetic determinants of polycystic ovary syndrome: Progress and future directions
Jones, M. R., & Goodarzi, M. O. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.04.040 · Cited by 117
New gene variants alter type 2 diabetes risk predominantly through reduced beta-cell function
Perry, J. R., & Frayling, T. M. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32830349a1 · Cited by 117
The complex genetics of multiple sclerosis: pitfalls and prospects
Sawcer, S. J. (2008) · Brain · doi:10.1093/brain/awn081 · Cited by 134
“Direct GWAS remain beyond affordable and practical technologies at this time but indirect GWAS are possible and have proven to be a highly successful means to identify common variants influencing susceptibility to complex disease (Duerr et al., 2006; Easton et al., 2007; Gudmundsson et al., 2007; Hampe et al., 2007; H…”
BackgroundTaneera, J., Fadista, J., Ahlqvist, E., Atac, D., Ottosson-Laakso, E., Wollheim, C. B., & Groop, L. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddu610 · Cited by 115
Self-citationKapur, K., Johnson, T., Beckmann, N. D., Sehmi, J., Tanaka, T., Kutalik, Z., Styrkársdóttir, U., Zhang, W., Marek, D., Gudbjartsson, D. F., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001035 · Cited by 123
Zeng, H., Guo, M., Zhou, T., Tan, L., Chong, C. N., Zhang, T., Dong, X., Xiang, J. Z., Yu, A. S., Yue, L., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.07.002 · Cited by 114
Kim, C., Kang, D., Lee, E. K., & Lee, J. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2062384 · Cited by 125
Into the Wild: GWAS Exploration of Non-coding RNAs
Giral, H., Landmesser, U., & Kratzer, A. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00181 · Cited by 125
Polymorphisms within the Novel Type 2 Diabetes Risk Locus MTNR1B Determine β-Cell Function
Staiger, H., Machicao, F., Schäfer, S. A., Kirchhoff, K., Kantartzis, K., Guthoff, M., Silbernagel, G., Stefan, N., Häring, H.-U., & Fritsche, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003962 · Cited by 116
The Genetics of Type 2 Diabetes: A Realistic Appraisal in 2008
Florez, J. C. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1345 · Cited by 117
Self-citationMurabito, J. M., White, C. C., Kavousi, M., Sun, Y. V., Feitosa, M. F., Nambi, V., Lamina, C., Schillert, A., Coassin, S., Bis, J. C., et al. (2012) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.111.961292 · Cited by 115
Hepatic Glucokinase Expression Is Associated with Lipogenesis and Fatty Liver in Humans
Peter, A., Stefan, N., Cegan, A., Walenta, M., Wagner, S., Königsrainer, A., Königsrainer, I., Machicao, F., Schick, F., Häring, H.-U., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2017 · Cited by 115
Franks, P. W., Rolandsson, O., Debenham, S. L., Fawcett, K. A., Payne, F., Dina, C., Froguel, P., Mohlke, K. L., Willer, C., Olsson, T., et al. (2008) · Diabetologia · doi:10.1007/s00125-007-0887-6 · Cited by 115
“[10] and DGI [11], where rs4416547 and rs10012946 were substituted as proxy markers.”
Orchestration of Glucose Homeostasis
Bergman, R. N. (2007) · Diabetes · doi:10.2337/db07-9903 · Cited by 114
The Diverse Functions of IMP2/IGF2BP2 in Metabolism
Dai, N. (2020) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2020.05.007 · Cited by 114
Angelakopoulou, A., Shah, T., Sofat, R., Shah, S., Berry, D. J., Cooper, J., Palmen, J., Tzoulaki, I., Wong, A., Jefferis, B. J., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr225 · Cited by 113
Umeno, J., Asano, K., Matsushita, T., Matsumoto, T., Kiyohara, Y., Iida, M., Nakamura, Y., Kamatani, N., & Kubo, M. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21651 · Cited by 113
Targeting microRNAs in obesity
Xie, H., Sun, L., & Lodish, H. F. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903190707 · Cited by 124
“Recently, many genome-wide association studies have identified susceptibility loci and gene polymorphisms for obesity and type 2 diabetes [94-98].”
BackgroundGenetics of Type 2 Diabetes: Insights into the Pathogenesis and Its Clinical Application
Sun, X., Yu, W., & Hu, C. (2014) · BioMed Research International · doi:10.1155/2014/926713 · Cited by 111
Genome-wide association studies: a primer
Corvin, A., Craddock, N., & Sullivan, P. F. (2010) · Psychological Medicine · doi:10.1017/s0033291709991723 · Cited by 110
Imamura, M., Maeda, S., Yamauchi, T., Hara, K., Yasuda, K., Morizono, T., Takahashi, A., Horikoshi, M., Nakamura, M., Fujita, H., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds113 · Cited by 111
Teo, Y. Y. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3282f5dd77 · Cited by 126
Enrichment of sequencing targets from the human genome by solution hybridization
Tewhey, R., Nakano, M., Wang, X., Pabón-Peña, C., Novak, B., Giuffre, A., Lin, E., Happe, S., Roberts, D. N., LeProust, E. M., et al. (2009) · Genome Biology · doi:10.1186/gb-2009-10-10-r116 · Cited by 110
“The 9p21 interval has been associated with coronary artery disease [18,19] and type 2 diabetes [20-22].”
BackgroundSelf-citationGenetic Markers for Prediction of Normal Tissue Toxicity After Radiotherapy
Alsner, J., Andreassen, C. N., & Overgaard, J. (2008) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2007.10.004 · Cited by 120
Palmer, N. D., Goodarzi, M. O., Langefeld, C. D., Ziegler, J. T., Norris, J. M., Haffner, S. M., Bryer‐Ash, M., Bergman, R. N., Wagenknecht, L. E., Taylor, K. D., et al. (2008) · Diabetes · doi:10.2337/db07-1169 · Cited by 118
“12 1,410 1,319 (375) 1,472 1,170 (83) 1,017 385 (3) 0.”
ResultInfluentialMitochondrial dysfunction in pancreatic β-cells in Type 2 Diabetes
Mulder, H., & Ling, C. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.05.015 · Cited by 129
“During the last year a number of genome wide scans of patients with Type 2 Diabetes have been published (Saxena et al., 2007; Scott et al., 2007; Sladek et al., 2007; Zeggini et al., 2007).”
Background
Metadata
- Authors
- Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., Hughes, T. E., Groop, L., Altshuler, D., Almgren, P., Florez, J. C., Meyer, J., Ardlie, K., Bengtsson Boström, K., Isomaa, B., Lettre, G., Lindblad, U., Lyon, H. N., Melander, O., Newton-Cheh, C., Nilsson, P., Orho-Melander, M., Råstam, L., Speliotes, E. K., Taskinen, M.-R., Tuomi, T., Guiducci, C., Berglund, A., Carlson, J., Gianniny, L., Hackett, R., Hall, L., Holmkvist, J., Laurila, E., Sjögren, M., Sterner, M., Surti, A., Svensson, M., Svensson, M., Tewhey, R., Blumenstiel, B., Parkin, M., DeFelice, M., Barry, R., Brodeur, W., Camarata, J., Chia, N., Fava, M., Gibbons, J., Handsaker, B., Healy, C., Nguyen, K., Gates, C., Sougnez, C., Gage, D., Nizzari, M., Gabriel, S. B., Chirn, G.-W., Ma, Q., Parikh, H., Richardson, D., Ricke, D., & Purcell, S.
- Affiliations
- Broad Institute (US)
- Broad Institute of Harvard and Massachusetts Institute of Technology (MIT), Cambridge, MA 02142, USA.
- ORCID
- Saxena, Richa
- Voight, Benjamin F.
- Lyssenko, Valeriya
- Chen, Hong
- Kathiresan, Sekar
- Hirschhorn, Joel N.
- Daly, Mark J.
- Hughes, Thomas E.
- Groop, Leif
- Altshuler, David
- Almgren, Peter
- Ardlie, Kristin
- Lettre, Guillaume
- Lindblad, Ulf
- Melander, Olle
- Nilsson, Peter
- Speliotes, Elizabeth K.
- Taskinen, Marja-Riitta
- Hackett, Rachel
- Tewhey, Ryan
- DeFelice, Matthew
- Gibbons, John
- Healy, Claire
- Gabriel, Stacey B.
- Parikh, Hemang
- Ricke, Darrell
- Purcell, Shaun
- Venue
- Science
- Published
- 2007-06
- Volume
- 316
- Issue
- 5829
- Pages
- 1331-1336
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2048755332
- Cited by
- 2,843
- References
- 28
- Citations by year
- 2026: 14 · 2025: 35 · 2024: 47 · 2023: 54 · 2022: 66 · 2021: 87 · 2020: 63 · 2019: 76 · 2018: 95 · 2017: 88 · 2016: 116 · 2015: 142 · 2014: 152 · 2013: 155 · 2012: 203
- FWCI
- 216.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- National Institutes of Health (5k23hl083102-02)
- National Heart, Lung, and Blood Institute (K23-HL-083102)
- National Human Genome Research Institute (U01HG004171)
- National Institute of Diabetes and Digestive and Kidney Diseases (K23-DK-65978-04, K23DK067288, F32DK079466, K23DK080145, K23DK065978)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Mapping and Diversity in Plants and Animals
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- type 2 diabetes, triglyceride levels, genetic loci, single nucleotide polymorphisms, CDKN2A/CDKN2B, IGF2BP2, CDKAL1, HHEX, SLC30A8, GCKR, non-coding variants, disease susceptibility, glucose metabolism, lipid metabolism
- MeSH terms
- Aged, Alleles, Blood Glucose, Chromosome Mapping, Chromosomes, Human, Pair 9, Diabetes Mellitus, Type 2, Female, Genetic Markers, Genotype, Haplotypes, Humans, Insulin Resistance, Introns, Male, Middle Aged, Triglycerides, Meta-Analysis as Topic, Genome, Human, Case-Control Studies, Insulin-Like Growth Factor Binding Proteins, Quantitative Trait, Heritable, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Adaptor Proteins, Signal Transducing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.